Clinical Trials Logo

Filter by:
NCT ID: NCT01516229 Completed - Achondroplasia Clinical Trials

Special Survey for Long Term Application

Start date: May 1, 1997
Phase: N/A
Study type: Observational

This study is conducted in Japan. The aim of this study is to assess the incidence rate of adverse drug reactions (ADRs) when using somatropin (Norditropin®) for treatment of for achondroplasia without epiphyseal line closure under normal clinical practice conditions.

NCT ID: NCT01515592 Completed - Clinical trials for Diabetes Mellitus, Type 2

Safety and Tolerability of Liraglutide in Healthy Japanese Male Volunteers

Start date: January 2006
Phase: Phase 1
Study type: Interventional

This trial is conducted in Japan. The aim of this trial is to assess the safety and tolerability of 20 µg/kg and 25 µg/kg liraglutide in healthy Japanese male subjects.

NCT ID: NCT01515423 Completed - Schizophrenia Clinical Trials

Study of Paliperidone Palmitate 3 Month and 1 Month Formulations for the Treatment of Patients With Schizophrenia

Start date: May 2012
Phase: Phase 3
Study type: Interventional

The purpose of this study is to demonstrate that a paliperidone palmitate 3 month formulation (PP3M) is as effective as the paliperidone palmitate 1 month formulation (PP1M) in the treatment of patients with schizophrenia who have been stabilized on PP1M.

NCT ID: NCT01515202 Completed - Clinical trials for Type 2 Diabetes Mellitus

Japanese Phase 1 Multiple Ascending Dose Study

Start date: March 2012
Phase: Phase 1
Study type: Interventional

The purpose of this clinical study is to assess the safety and tolerability of multiple oral doses of BMS-823778 in healthy Japanese subjects and Japanese patients with Type 2 Diabetes Mellitus.

NCT ID: NCT01514851 Completed - Hyperphosphatemia Clinical Trials

Phase III Double-blind Comparative Study of BAY77-1931 (Lanthanum Carbonate) With Calcium Carbonate

Start date: January 2006
Phase: Phase 3
Study type: Interventional

To assess the effect on reduction of serum phosphate and the safety of BAY77-1931 (Lanthanum Carbonate) in patients with hyperphosphatemia undergoing hemodialysis in a randomized, double-blind, parallel group study in comparison with Calcium carbonate.

NCT ID: NCT01514825 Completed - Clinical trials for Pharmacokinetic of YM150

A Study to Investigate the Plasma Concentration of YM150 After Repeated Administration to Elderly Subjects

Start date: November 2006
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety and plasma concentration change of YM150 after repeated administration to healthy elderly male and female subjects.

NCT ID: NCT01514240 Completed - Crohn's Disease Clinical Trials

Phase III Study of D9421-C 9 mg in Patients With Active Crohn's Disease in Japan

Start date: February 2012
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the clinical efficacy of D9421-C 9 mg once daily compared to Mesalazine 1 g three times a day to patients with mild to moderate active Crohn's disease affecting ileum, ileocecal region and/or ascending colon as defined by a score of 180-400 on the Crohn's Disease Activity Index (CDAI) by assessment of the remission after 8-week treatment defined by a CDAI score of ≤ 150.

NCT ID: NCT01514227 Completed - Clinical trials for Coronary Artery Disease

Nobori Dual Antiplatelet Therapy as Appropriate Duration

Start date: December 2011
Phase: Phase 4
Study type: Interventional

NIPPON trial is a prospective, randomized, trial comparing 6 and 18 months Dual Antiplatelet Therapy (DAPT) following Nobori stent deployment.

NCT ID: NCT01514019 Completed - Healthy Clinical Trials

An Open-label, Single-dose, Two-treatment, Randomized, Cross-over Study to Investigate the Effects of the SLCO2B1 c.1457C>T Polymorphism and Apple Juice on the Pharmacokinetics and Pharmacodynamics of Acebutolol in Healthy Korean and Japanese Volunteers

Start date: January 2012
Phase: Phase 4
Study type: Interventional

An open-label, single-dose, two-treatment, randomized, cross-over study to investigate the effects of the SLCO2B1 c.1457C>T polymorphism and apple juice on the pharmacokinetics and pharmacodynamics of acebutolol in healthy Korean and Japanese volunteers

NCT ID: NCT01513473 Completed - Diabetes Clinical Trials

A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes Mellitus

BEGIN™
Start date: January 16, 2012
Phase: Phase 3
Study type: Interventional

This trial is conducted in Africa, Asia, Europe and the United States of America (USA). The aim of this trial is to investigate the efficacy and safety of insulin degludec in children and adolescents with type 1 diabetes mellitus.